Retroelement silencing factor 1 (RESF1)

Retroelement silencing factor 1 (RESF1) is a nuclear protein encoded by the RESF1 gene on Chromosome 12. It is broadly expressed in multiple tissues including lymph nodes, spleen, thymus, bone marrow, liver, uterus, and ovaries, primarily associated with the immune system. RESF1 is predicted to bind histones and associate with histone methyltransferases, and is required for SETDB1-dependent silencing of endogenous retroviruses by maintaining repressive chromatin through heterochromatin formation. Its interactions include NANOG (regulation of cell fate in stem cells), MDM2 (cell cycle and apoptosis), CALML3 (epidermal development), and EXOC1 (immune response and potential links to schizophrenia networks). The protein consists mostly of random coil structures and is conserved across a wide range of species, indicating an evolutionary role likely connected to rapid adaptation, especially in response to pathogens and retroelements. RESF1 is studied more as a gene involved in fundamental cellular and immune processes rather than as a direct therapeutic target or biomarker[1][2][3][8][9][10].

Other names

C12orf35KIAA1551FLJ20696FLJ10652UTA2-1GETGonad expressed transcriptUncharacterized protein C12orf35

Not applicable (no known drugs target RESF1)